Loading...
Loading...
Among the 3 tracked institutional investors we monitor, TCRT (ALAUNOS THERAPEUTICS INC) is held with a combined value of $172.18K across 63,284 shares. The largest holder is VANGUARD GROUP INC with a position worth $97.10K. 2 funds increased their holdings.
Total Institutional Value
$172.18K
Total Shares Held
63,284
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $97.10K | 0.00% | +43.3% |
| 2 | BlackRock, Inc. | $48.26K | 0.00% | - |
| 3 | CITADEL ADVISORS LLC | $26.83K | 0.00% | +12.8% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of TCRT with a position worth $97.10K, representing 0.00% of their portfolio. In total, 3 institutional investors hold TCRT with a combined value of $172.18K.
Institutional investors hold $172.18K worth of TCRT stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $97.10K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TCRT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TCRT positions.
| 2026-10-15 |
SEC Schedule 13D (activist) and 13G (passive) filings for TCRT. Filed when an investor acquires 5%+ ownership.
Last Close
$2.63
2026-10-16
YTD
-19.8%
52% of 52-week range